We came across a bullish thesis on AbCellera Biologics Inc. on Investment Ideas by Antonio’s Substack by Antonio Linares. In this article, we will summarize the bulls’ thesis on ABCL. AbCellera Biologics Inc.’s share was trading at $5.98 as of October 2nd. ABCL’s trailing P/E was 19.92 according to Yahoo Finance.
Copyright: nexusplexus / 123RF Stock Photo
Abcellera is emerging as a highly promising biotechnology platform with the potential for exponential earnings growth over the...
